共 15 条
[3]
1-(5-Carboxy- and 5-carbamoylindol-1-yl)propan-2-ones as inhibitors of human cytosolic phospholipase A 2 α: Bioisosteric replacement of the carboxylic acid and carboxamide moiety[J] . Mark Hess,Alwine Schulze Elfringhoff,Matthias Lehr.Bioorganic & Medicinal Chemistry . 2007 (8)
[4]
COX-2 controversy: where are we and where do we go from here?[J] . Dinesh Khanna,Puja P Khanna,Daniel E Furst.Inflammopharmacology . 2005 (4)
[6]
The efficiency of multi-target drugs: the network approach might help drug design[J] . Péter Csermely,Vilmos ágoston,Sándor Pongor.Trends in Pharmacological Sciences . 2005 (4)
[7]
Strong links are important, but weak links stabilize them[J] . Peter Csermely.Trends in Biochemical Sciences . 2004 (7)
[8]
Prevention of thrombosis and vascular inflammation: benefits and limitations of selective or combined COX-1, COX-2 and 5-LOX inhibitors[J] . Giovanni de Gaetano,Maria Benedetta Donati,Chiara Cerletti.Trends in Pharmacological Sciences . 2003 (5)
[9]
Cyclooxygenase-1/2 (COX-1/COX-2) and 5-lipoxygenase (5-LOX) inhibitors of the 6,7-diaryl-2,3-1 H -dihydropyrrolizine type[J] . Holger Ulbrich,Bernd Fiebich,Gerd Dannhardt.European Journal of Medicinal Chemistry . 2002 (12)